Pirfenidone has been included in the health insurance in 2019, but whether the health insurance can be reimbursed or not depends on the local health insurance reimbursement policy.
Pirfenidone is used in the treatment of idiopathic interstitial lung fibrosis disease. Interstitial fibrosis is growing at a rate of 11% per year in recent years and is known as a ? tumor-like disease? Pirfenidone is also known as ? Excedrin? , is an inhibitor of cytokines, which is mainly used to inhibit cell activity and reduce cell proliferation and synthesis by inhibiting or modulating certain factors. Clinically, pirfenidone can be used to treat the decline in lung function in patients with interstitial fibrosis, improve the quality of life of patients and prolong their lives.
Now what does it take for pirfenidone to be reimbursed?
Pirfenidone was launched in China in 2016 and was included in the scope of medical insurance in 2019, with a reimbursement rate of 80%. However, it should be reminded that although it is said that pirfenidone has been included in the medical insurance, but the reimbursement conditions are different in each region, which should be decided according to the local medical insurance policy.
And according to netizens, some local hospitals simply do not have into pirfenidone, to go to the provincial capital city hospitals, and must be hospitalized to reimbursement, but generally hospitalization time will not be too long, so generally discharged from the hospital doctor will not give you to open too many medicines to take back to the hospital, the doctor is also the patient will be advised to self-financing to outside the pharmacy to buy. There are also many netizens who say that it's hard to buy pirfenidone in their local hospitals, let alone get reimbursed for it.
So what are the reasons for the difficulty in getting reimbursed for pirfenidone? The main reason is that although pirfenidone is included in the medical insurance, it does not belong to the catalog of chronic disease treatment, so that only the inclusion of pirfenidone in the catalog of chronic disease treatment can fundamentally solve the problem of reimbursement difficulties.
The current online price of pirfenidone is 700 yuan/100mg/54 capsules, as the ordinary people, this is really a lot of money, and I hope that the problem of reimbursement difficulties can be solved as soon as possible, so that the ordinary people can afford to use it.